The rising prevalence in GLP-1 agonists for diabetes has sparked a question about application forms : transdermal systems versus tablets . Traditionally , GLP-1 drugs were exclusively available in tablet form, but the introduction of skin applications offers a new choice . Transdermal systems might be advantageous for individuals facing issues s… Read More